Fig. 4From: Treatment with Botulinum toxin A in a total population of children with cerebral palsy - a retrospective cohort registry studyBTX-A treatment in relation to GMFCS level. Proportion of children (%) treated with BTX-A based on GMFCS level. The line segments represent the upper and lower bounds of the 95% confidence intervals. N = 3028Back to article page